115 related articles for article (PubMed ID: 9236918)
1. A sensitive enzyme immunoassay of human thyroid-stimulating hormone (TSH) using bispecific F(ab')2 fragments recognizing polymerized alkaline phosphatase and TSH.
Morimoto K; Inouye K
J Immunol Methods; 1997 Jun; 205(1):81-90. PubMed ID: 9236918
[TBL] [Abstract][Full Text] [Related]
2. Bispecific-Ab-based immunoassay of thyroid-stimulating hormone.
Inouye K
Cancer Immunol Immunother; 1997; 45(3-4):159-61. PubMed ID: 9435863
[TBL] [Abstract][Full Text] [Related]
3. Method for the preparation of bispecific F(ab')2mu fragments from mouse monoclonal antibodies of the immunoglobulin M class and characterization of the fragments.
Morimoto K; Inouye K
J Immunol Methods; 1999 Apr; 224(1-2):43-50. PubMed ID: 10357205
[TBL] [Abstract][Full Text] [Related]
4. Use of high-capacity surface with oriented recombinant antibody fragments in a 5-min immunoassay for thyroid-stimulating hormone.
Brockmann EC; Vehniäinen M; Pettersson K
Anal Biochem; 2010 Jan; 396(2):242-9. PubMed ID: 19818328
[TBL] [Abstract][Full Text] [Related]
5. Studies of possible antiidiotypic control mechanisms in Graves' disease.
Moynier M; Montano J; Williams RC; Pathak D; DeGroot LC; Hill BL; Marshall NJ
J Lab Clin Med; 1988 Jul; 112(1):99-108. PubMed ID: 2839588
[TBL] [Abstract][Full Text] [Related]
6. Tumor targeting with newly designed biparatopic antibodies directed against two different epitopes of the carcinoembryonic antigen (CEA).
Robert B; Dorvillius M; Buchegger F; Garambois V; Mani JC; Pugnières M; Mach JP; Pèlegrin A
Int J Cancer; 1999 Apr; 81(2):285-91. PubMed ID: 10188732
[TBL] [Abstract][Full Text] [Related]
7. Bispecific rabbit Fab'-bovine serum albumin conjugate used in hemagglutination immunoassay for beta-microseminoprotein.
Yukawa N; Osawa M; Saito T; Hasegawa T; Matsuda H; Takahama K; Takeichi S
J Immunoassay; 1997 Aug; 18(3):215-33. PubMed ID: 9257262
[TBL] [Abstract][Full Text] [Related]
8. Bispecific F (ab')2 monomer prepared with anti-CD3 and anti-tumor monoclonal antibodies is most potent in induction of cytolysis of human T cells.
Nitta T; Yagita H; Azuma T; Sato K; Okumura K
Eur J Immunol; 1989 Aug; 19(8):1437-41. PubMed ID: 2528460
[TBL] [Abstract][Full Text] [Related]
9. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
[TBL] [Abstract][Full Text] [Related]
10. [Bi-specific F(ab')2 enhances cytolytic activities of LAK cells against human small cell lung cancer (SCLC)].
Azuma A; Niitani H
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Sep; 29(9):1132-7. PubMed ID: 1661346
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/anti-CD3 F(ab')2 bispecific monoclonal antibody.
Negri DR; Tosi E; Valota O; Ferrini S; Cambiaggi A; Sforzini S; Silvani A; Ruffini PA; Colnaghi MI; Canevari S
Br J Cancer; 1995 Oct; 72(4):928-33. PubMed ID: 7547242
[TBL] [Abstract][Full Text] [Related]
12. Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments.
Glennie MJ; McBride HM; Worth AT; Stevenson GT
J Immunol; 1987 Oct; 139(7):2367-75. PubMed ID: 2958547
[TBL] [Abstract][Full Text] [Related]
13. OKT3 F(ab')2 fragments--retention of the immunosuppressive properties of whole antibody with marked reduction in T cell activation and lymphokine release.
Woodle ES; Thistlethwaite JR; Ghobrial IA; Jolliffe LK; Stuart FP; Bluestone JA
Transplantation; 1991 Aug; 52(2):354-60. PubMed ID: 1908148
[TBL] [Abstract][Full Text] [Related]
14. Localization of monoclonal antibody G250 and bispecific monoclonal antibody CD3/G250 in human renal-cell carcinoma xenografts: relative effects of size and affinity.
van Dijk J; Zegveld ST; Fleuren GJ; Warnaar SO
Int J Cancer; 1991 Jul; 48(5):738-43. PubMed ID: 1830033
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies.
Welfringer F; d'Athis P; Scherrmann JM; Hervé F
J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies to placental alkaline phosphatase: preclinical evaluation in a human xenograft tumour model of F(ab')2 and Fab fragments.
Durbin H; Milligan EM; Mather SJ; Tucker DF; Raymond R; Bodmer WF
Int J Cancer Suppl; 1988; 2():59-66. PubMed ID: 3162446
[TBL] [Abstract][Full Text] [Related]
17. Development of a sensitive, rapid, biotin-streptavidin based chemiluminescent enzyme immunoassay for human thyroid stimulating hormone.
Lin Z; Wang X; Li ZJ; Ren SQ; Chen GN; Ying XT; Lin JM
Talanta; 2008 May; 75(4):965-72. PubMed ID: 18585170
[TBL] [Abstract][Full Text] [Related]
18. Different behaviour of mouse-human chimeric antibody F(ab')2 fragments of IgG1, IgG2 and IgG4 sub-class in vivo.
Buchegger F; Pèlegrin A; Hardman N; Heusser C; Lukas J; Dolci W; Mach JP
Int J Cancer; 1992 Feb; 50(3):416-22. PubMed ID: 1735611
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.
Molthoff CF; Pinedo HM; Schlüper HM; Nijman HW; Boven E
Br J Cancer; 1992 May; 65(5):677-83. PubMed ID: 1586596
[TBL] [Abstract][Full Text] [Related]
20. Effect of unlabelled monoclonal antibodies on the biodistribution of 111In-labelled anti-prostate-specific acid phosphatase monoclonal antibodies in the mouse model.
Peräalä-Heape M; Vihko P; Vihko R
Anticancer Res; 1991; 11(3):1327-31. PubMed ID: 1888168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
